The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ...

Dec 15 (Reuters) - The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

PICKING up her phone, Oonagh Van der Berg goes to read a WhatsApp message – but the 45-year-old, from Belfast, can’t focus.

Novo Nordisk finds itself navigating significant operational and market headwinds. The company is intensely focused on maintaining its leadership in the obes ...

Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as new therapies expand global market leadership.

Test your grasp of the week’s major stories with a quick round of questions. Find the answers at the end ...

Ozempic has officially arrived in India at a comparatively affordable price, sparking buzz among diabetes and weight loss ...